TG THERAPEUTICS, INC. (TGTX) Free cash flow 2016–2025
TG THERAPEUTICS, INC. (TGTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$25.0MFY2025 · since FY2016: -$61.9M → -$25.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$25.0M | +38.4% |
| FY2024 | -$40.6M | -29.1% |
| FY2023 | -$31.4M | +82.2% |
| FY2022 | -$176.2M | +40.5% |
| FY2021 | -$296.0M | -37.8% |
| FY2020 | -$214.9M | -61.6% |
| FY2019 | -$132.9M | -3.0% |
| FY2018 | -$129.0M | -37.6% |
| FY2017 | -$93.8M | -51.4% |
| FY2016 | -$61.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice